| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 55,131 | 104,328 | 39,563 | 271,949 | | Cost of Revenue | 48,252 | 88,345 | 29,268 | 239,485 | | | Gross Profit | 6,879 | 15,983 | 10,295 | 32,464 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,100 | 6,713 | 7,322 | 8,641 | | Non Recurring | 495 | (116) | (379) | (96) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 284 | 9,386 | 3,352 | 23,919 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 853 | | Earnings Before Interest And Taxes | (221) | 9,386 | 3,352 | 24,772 | | Interest Expense | (295) | 133 | 162 | 226 | | Income Before Tax | 74 | 9,253 | 3,190 | 24,546 | | Income Tax Expense | (971) | 2,268 | 804 | 9,413 | | Minority Interest | 24 | 37 | 11 |
-
| | | | Net Income From Continuing Ops | 1,069 | 7,022 | 2,397 | 15,133 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,069 | 7,022 | 2,397 | 15,133 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,069 | $7,022 | $2,397 | $15,133 |
|
0.11% Nasdaq 
0.01%
Income Statement
